Evidence map›Paper›PMID 40481209›Full record

ArticleNature medicine2025

A multimodal vision foundation model for clinical dermatology.

Siyuan Yan, Zhen Yu, Clare Primiero, Cristina Vico-Alonso, Zhonghua Wang, Litao Yang, Philipp Tschandl, Ming Hu, Lie Ju, Gin Tan and 15 more

Abstract read
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Observational
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Siyuan YanAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Zhen YuAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Clare PrimieroFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
Cristina Vico-AlonsoVictorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.
Zhonghua WangAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Litao YangAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Philipp TschandlDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-0391-7810
Ming HuAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Lie JuAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
Gin TaneResearch Centre, Monash University, Melbourne, Victoria, Australia.
Vincent TangNVIDIA AI Technology Center, Singapore, Singapore.
Aik Beng NgNVIDIA AI Technology Center, Singapore, Singapore.ORCID http://orcid.org/0009-0009-1291-1753
David PowelleResearch Centre, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-6639-6250
Paul BonningtonThe University of Queensland, Brisbane, Queensland, Australia.
Simon SeeNVIDIA AI Technology Center, Singapore, Singapore.
Elisabetta MagnaterraSection of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Peter FergusonMelanoma Institute Australia, Sydney, New South Wales, Australia.
Jennifer NguyenVictorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.
Pascale GuiteraVictorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.
Jose BanulsDepartment of Dermatology, Hospital General Universitario de Alicante, ISABIAL, Alicante, Spain.
Monika JandaCentre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Victoria MarVictorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.
Harald KittlerDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-0051-8016
H Peter SoyerFrazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-4770-561X
Zongyuan GeAIM for Health Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia. zongyuan.ge@monash.edu.ORCID http://orcid.org/0000-0002-5880-8673

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing and treating skin diseases require advanced visual skills across domains and the ability to synthesize information from multiple imaging modalities. While current deep learning models excel at specific tasks such as skin cancer diagnosis from dermoscopic images, they struggle to meet the complex, multimodal requirements of clinical practice. Here we introduce PanDerm, a multimodal dermatology foundation model pretrained through self-supervised learning on over 2 million real-world skin disease images from 11 clinical institutions across 4 imaging modalities. We evaluated PanDerm on 28 diverse benchmarks, including skin cancer screening, risk stratification, differential diagnosis of common and rare skin conditions, lesion segmentation, longitudinal monitoring, and metastasis prediction and prognosis. PanDerm achieved state-of-the-art performance across all evaluated tasks, often outperforming existing models when using only 10% of labeled data. We conducted three reader studies to assess PanDerm's potential clinical utility. PanDerm outperformed clinicians by 10.2% in early-stage melanoma detection through longitudinal analysis, improved clinicians' skin cancer diagnostic accuracy by 11% on dermoscopy images and enhanced nondermatologist healthcare providers' differential diagnosis by 16.5% across 128 skin conditions on clinical photographs. These results show PanDerm's potential to improve patient care across diverse clinical scenarios and serve as a model for developing multimodal foundation models in other medical specialties, potentially accelerating the integration of artificial intelligence support in healthcare.

Indexed as

DermatologyMelanomaSkin DiseasesSkin NeoplasmsDeep LearningDermoscopyDiagnosis, DifferentialHumans

Identifiers

PMID40481209
PMCPMC12353815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.